《2022—2030年全球卫生部门关于艾滋病、病毒性肝炎和性传播疾病行动计划》在病毒性肝炎领域的要求:解读及临床实践  

Key points for viral hepatitis management in"Global health sector strategies on,respectively,HIV,viral hepatitis and sexually transmitted infections for the period 2022—2030":interpretation and clinical practice

作　　者：杨瑞锋[1] 陈红松[1] Ruifeng Yang;Hongsong Chen(Peking University People′s Hospital,Peking University Hepatology Institute,National Clinical Research Center for Infectious Disease,Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases,Beijing 100044,China)

机构地区：[1]北京大学人民医院,北京大学肝病研究所,国家感染性疾病临床医学研究中心分中心,丙型肝炎和肝病免疫治疗北京市重点实验室,北京100044

出　　处：《中华检验医学杂志》2023年第1期12-18,共7页Chinese Journal of Laboratory Medicine

摘　　要：2022年6月,世界卫生组织发布了《2022—2030年全球卫生部门关于艾滋病、病毒性肝炎和性传播疾病行动计划》,对消除危害人类健康的重大传染病提出了更具体和宏观的目标。该文结合我国病毒性肝炎临床诊治实践,旨在阐述贯彻该行动计划,实现消除病毒性肝炎目标过程中取得的进展及面临的挑战。In June 2022,the World Health Organization released the"Global health sector strategies on,respectively,HIV,viral hepatitis and sexually transmitted infections for the period 2022—2030".It sets more specific and large-scale goals for eliminating the major infectious diseases,which are still threatening human health.In combination with our clinical practice,present document highlights the advances and challenges in the process of implementing the suggested strategies and ways to achieve the stated goal of eliminating the viral hepatitis in China.

关 键 词：病毒性肝炎 消除 行动计划 

分 类 号：R512.62[医药卫生—内科学]